People · Operator
Named in public records as an officer, director or promoter · active 2012–2022 · Other Health Care, Biotechnology, Computers
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Bigfoot Biomedical, Inc. | — | Other Health Care | Series C | $144.1M | $1.3B | 2015 |
| WellDoc, Inc. | — | Other Health Care | Series B | $92.4M | $644.1M | 2012 |
| CorriXR Therapeutics, Inc. | — | Biotechnology | Series A | $6.5M | $90.1M | 2022 |
| CanSurround, PBC | — | Other Health Care | Seed | $2.8M | $47.6M | 2014 |
| Opargo, LLC | — | Computers | Seed | $2.4M | $45.4M | 2015 |
Jon Brilliant at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jon Brilliant on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Levy | 1 | 9 |
| Juan Enriquez | 1 | 6 |
| Stella Vnook | 1 | 5 |
| Matthew Levine | 1 | 5 |
| Karen Talmadge | 1 | 3 |
| Ryan Sysko | 1 | 2 |
| Brett Hale | 1 | 2 |
| Paul Wiley | 1 | 2 |
| Hyuk-Jeen Suh | 1 | 2 |
| Anand Iyer | 1 | 2 |
| Terry Lierman | 1 | 2 |
| Stewart Greenebaum | 1 | 2 |
| Paul LaFontaine | 1 | 2 |
| Bryan Mazlish | 1 | 2 |
| Suzanne Clough | 1 | 1 |
| Michael Greenebaum | 1 | 1 |
| Suzanne I. Clough | 1 | 1 |
| Michael I. Greenebaum | 1 | 1 |
| Donald V. Almeida | 1 | 1 |
| Anand K. Iyer | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.